Education and Research Category
Published: Oct 31st, 2012
Woody Johnson, owner of the New York Jets, wrote an article featured in the Wall Street Journal this week that detailed the expenses of diabetes on the government and society as a whole. Telling the story with the experience gained from his own daughter’s diabetes, Mr. Johnson urges you to ask your Senators and Representatives to Support Special Diabetes Program (SDP).
Published: Apr 23rd, 2012
UF Type 1 Diabetes Researcher and JDRF Research Summit presenter Dr. Desmond Schatz discusses the importance of screening.
Published: Mar 28th, 2012
Did you hear the great news about the first artificial pancreas outpatient trial in the U.S. being approved by the FDA? To help ensure that progress like the artificial pancreas continues to improve the lives of those with diabetes by simply sending an email to your members of Congress.
Published: Feb 27th, 2012
University of Florida doctoral candidates and research fellows will present type 1 diabetes research findings during the 30th Annual Pediatric Science Days on March 8, 2012.
Published: Feb 27th, 2012
A recent study of 182 type 1 diabetes patients revealed that 10% of those who had the disease for 31 to 40 years still produced C-peptide and showed intact beta-cell functioning, suggesting insulin production may continue for decades after the disease’s onset.
Published: Feb 22nd, 2012
Type 2 diabetes strikes people of all ages, and early symptoms are subtle. In fact, about one out of three people with type 2 diabetes don’t know they have it. If you believe that you may be at risk for Diabetes, consider a appointment to one of our board certified endocrinologists. For an appointment today call 352-265-0139
Published: Nov 13th, 2011
Last week JDRF launched the Artificial Pancreas Campaign. Now, they need your help. You can help the FDA understand what having access to the Artificial Pancreas will mean to those living with diabetes by signing a petition. The goal of the initiative is to convince the FDA to adopt the recommendations of clinical experts to advance the development of an artificial pancreas, a device which has the potential to be the most revolutionary advancement in the treatment of T1D since the discovery of insulin.
Published: Oct 25th, 2011
“UF works to unlock causes and cures so kids like Matt Danner won’t be sidelined by their disease.” Florida Magazine recently featured an article highlighting the UF Diabetes Center researchers, physicians, and a special patient, Matt Danner.
Published: Oct 14th, 2011
JDRF’s Countdown Magazine featured information on TrialNet’s AntiCD3 prevention trial. Phase I of the trial aims to evaluate an anti-CD3 drug can halt, or reverse, diabetes in high-risk groups.
Published: Oct 12th, 2011
Anastasia Albanese-O’Neill, R.N., a consultant for the UF Diabetes Center of Excellence, spoke about the importance of National Institutes of Health-funded diabetes research and its effects on patients and families at a congressional briefing in Washington D.C.